Elena N Klyushnenkova

Title: Innovations and Contributions of Elena N Klyushnenkova

Introduction

Elena N Klyushnenkova is a prominent inventor based in Baltimore, MD, known for her significant contributions to medical science and immunology. With a total of seven patents to her name, she has made remarkable strides in the development of innovative treatments for prostate cancer and transplant immunology.

Latest Patents

One of her latest patents focuses on prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccines to treat or prevent prostate cancer. This invention relates to immunogenic peptides derived from human prostate cancer antigen and their application as vaccines. Additionally, it involves dendritic cells from patients with prostate cancer that have been exposed to these peptides, as well as T-cells specific for PSA-activated peptides, aimed at treating or preventing prostate cancer. Another notable patent involves methods for inducing a reduced immune response to transplants using fibroblasts or supernatants from fibroblast cultures. This method effectively reduces host rejection of transplants without compromising the immune response to other foreign antigens.

Career Highlights

Elena has worked with several esteemed organizations, including Osiris Therapeutics, Inc. and the University System of Maryland. Her work in these institutions has been pivotal in advancing research and development in her fields of expertise.

Collaborations

Throughout her career, Elena has collaborated with notable professionals, including Kevin R McIntosh and Joseph D Mosca. These collaborations have further enriched her research and contributed to her innovative projects.

Conclusion

Elena N Klyushnenkova's contributions to medical science through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to inspire advancements in cancer treatment and transplant immunology.